|
2019 Conference Publication Lysozyme amyloidosis – Two novel cases with newly described genetic mutationsMcMichael, L., Chang, S., Gibbs, S., Mollee, P., Gillmore, J., Horvath, N., Crail, S. and Jobert, A. (2019). Lysozyme amyloidosis – Two novel cases with newly described genetic mutations. ISN World Congress of Nephrology (WCN) 2024, Buenos Aires, Argentina, 13-16 April 2024. New York, NY United States: Elsevier. doi: 10.1016/j.ekir.2019.05.590 |
|
2019 Conference Publication Validation of the Boston University staging system in AL amyloidosisTomlinson, R., Matigain, N. and Mollee, P. (2019). Validation of the Boston University staging system in AL amyloidosis. 29th European Hematology Association Congress EHA24, Madrid, Spain, 13-16 June 2024. Philadelphia, PA United States: Wiley. doi: 10.1097/01.hs9.0000567024.85321.eb |
|
2019 Conference Publication The epidemiology of amyloidosis in AustraliaWisniowski, Brendan, McLeod, Donald, Adams, Rebecca, Harvey, Yasmin, Armes, Jane, Papadimos, David, Brown, Ian, McGuire, Lloyd and Mollee, Peter (2019). The epidemiology of amyloidosis in Australia. XVI International Symposium on Amyloidosis, Kumamoto, Japan, 26-29 March 2018. Abingdon, Oxfordshire United Kingdom: Taylor & Francis. doi: 10.1080/13506129.2019.1582481 |
|
2019 Conference Publication Beta-migrating paraproteins: a need for harmonisation of reportingWijeratne, Nilika, Tate, Jillian R., Du Toit, Stephen, Smith, Joel D., Soepnel, Andrew, Choy, Kay Weng, Martin, Helen, Henry, Robyn, Glegg, Kaye, Byrnes, Elizabeth, Wienholt, Louise and Mollee, Peter (2019). Beta-migrating paraproteins: a need for harmonisation of reporting. Pathology Update 2019, Melbourne, VIC Australia, 22-24 February 2019. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.pathol.2018.12.323 |
|
2019 Conference Publication Development of an individualized, supervised exercise intervention as standard care for patients with Multiple MyelomaNicol, Jennifer, Woodrow, Carmel, Burton, Nicola, Hill, Michelle, Skinner, Tina, Mollee, Peter and Nicol, Andrew (2019). Development of an individualized, supervised exercise intervention as standard care for patients with Multiple Myeloma. 17th International Myeloma Workshop, Boston, MA, United States, 12-15 September 2019. New York, United States: Elsevier. doi: 10.1016/j.clml.2019.09.355 |
|
2018 Conference Publication The Tumour Microenvironment as an Independent Prognostic Biomarker in Follicular LymphomaTobin, J., Keane, C., Mollee, P., Birch, S., Gould, C., Gunawardana, J., Hoang, T., Savarimuthu, S., Ma, T., Li, L., Murigneux, V. , Fink, L., Matigian, N. and Gandhi, M. K. (2018). The Tumour Microenvironment as an Independent Prognostic Biomarker in Follicular Lymphoma. RACP Congress 2018, Disruption for Healthy Futures, Sydney, NSW Australia, 14–16 May 2018. Hoboken, NJ United States: Wiley. doi: 10.1111/imj.2_13826 |
|
2018 Conference Publication Perspectives on physical activity of clinical haematologists and their patients with multiple myelomaNicol, Jennifer L., Burton, Nicola W., Woodrow, Carmel, Mollee, Peter, Hill, Michelle M., Nicol, Andrew J. and Skinner, Tina L. (2018). Perspectives on physical activity of clinical haematologists and their patients with multiple myeloma. COSA's 45th Annual Scientific Meeting, Mesothelioma and Gastro‐Intestinal Cancers: Technology and Genomics, Perth, Western Australia, 13–15 November 2018. Hoboken, NJ United States: Wiley. |
|
2018 Conference Publication Activation of Fc Gamma Receptor-Dependent Responses to Therapeutic Antibodies By Nurse like Cells Requires PI3KdeltaChen, Yu-Chen Enya, Burgess, Melinda Lea, Blumenthal, Antje, Mapp, Sally, Mollee, Peter, Gill, Devinder and Saunders, Nicholas Andrew (2018). Activation of Fc Gamma Receptor-Dependent Responses to Therapeutic Antibodies By Nurse like Cells Requires PI3Kdelta. 60th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA United States, 1-4 December 2018. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2018-99-109719 |
|
2017 Conference Publication The tumor microenvironment is independently prognostic of conventional and clinicogenetic risk models in follicular lymphomaTobin, Joshua W. D., Keane, Colm, Mollee, Peter, Birch, Simone, Gould, Clare, Gunawardana, Jay, Hoang, Thanh, Ma, Ti, Abro, Emad Uddin, Shanavas, Mohamed, Yoo, Hyung, Li, Li, Scuffham, Paul, Murigneux, Valentine, Fink, Lynn, Matigian, Nicholas, Vari, Frank, Francis, Santiyagu and Gandhi, Maher K. (2017). The tumor microenvironment is independently prognostic of conventional and clinicogenetic risk models in follicular lymphoma. 59th Annual Meeting of the American-Society-of-Hematology (ASH), Atlanta, GA United States, 9-12 December 2017. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood.V130.Suppl_1.728.728 |
|
2017 Conference Publication First Australian registry of patients with wild type cardiac amyloidosis (ATTRwt): Queensland experienceBurrage, M., Korczyk, D. and Mollee, P. (2017). First Australian registry of patients with wild type cardiac amyloidosis (ATTRwt): Queensland experience. ESC Congress 2017, Barcelona, Spain, 26-30 August 2017. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/eurheartj/ehx502.1955 |
|
2017 Conference Publication Combination bone marrow imaging using PET-MRI in plasma cell dyscrasias: correlation with prognostic laboratory values and clinicopathological diagnosisTate, Courtney, Miles, Kenneth and Mollee, Peter (2017). Combination bone marrow imaging using PET-MRI in plasma cell dyscrasias: correlation with prognostic laboratory values and clinicopathological diagnosis. 16th International Myeloma Workshop, New Delhi, India, 1-4 March 2017. Elsevier BV. doi: 10.1016/j.clml.2017.03.081 |
|
2017 Conference Publication Cardiac amyloid imaging with 18F-florbetaben positron emission tomography: a pilot studyLaw, W. Phillip, Wang, William, Moore, Peter, Mollee, Peter and Ng, Arnold (2017). Cardiac amyloid imaging with 18F-florbetaben positron emission tomography: a pilot study. XVth International Symposium on Amyloidosis, Indianapolis, IN, USA, 2014. Abingdon, Oxfordshire, United Kingdom: Taylor & Francis. doi: 10.1080/13506129.2017.1281120 |
|
2017 Conference Publication Evaluation of bortezomib use in Queensland public hospitals for the treatment of multiple myelomaWalpole, Euan, Mollee, Peter, McPherson, Ian, Loke, Crystal and Hollingworth, Samantha (2017). Evaluation of bortezomib use in Queensland public hospitals for the treatment of multiple myeloma. COSA's 44th Annual Scientific Meeting, Sydney, NSW, Australia, 13-15 November 2017. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12799 |
|
2017 Conference Publication The Effect of Immune Checkpoint Inhibitors in Patients with Concomitant Advanced Melanoma and Chronic Lymphocytic LeukaemiaTobin, Joshua W. D., Royle, Jane, Mason, Robert, Michael, Millward, Lydia, Warburton, Sandhu, Shahneen, Haydon, Andrew, Long, Georgina, Carlino, Matteo, Smith, Jessica L., Dearden, Helen, Mollee, Peter, Gill, Devinder, Mapp, Sally, Atkinson, Victoria and Keane, Colm (2017). The Effect of Immune Checkpoint Inhibitors in Patients with Concomitant Advanced Melanoma and Chronic Lymphocytic Leukaemia. 59th Annual Meeting of the American-Society-of-Hematology (ASH), Atlanta, GA United States, 9-12 December 2017. Washington, DC United States: American Society of Hematology. |
|
2017 Conference Publication Catheter-Associated Bloodstream Infections (CA-BSI) in Adults with Cancer: A Prospective Randomized Controlled TrialMollee, Peter, Okano, Satomi, Looke, David, Kennedy, Glen, Harper, John, Clouston, John, Van Kuilenburg, Rosita, Geary, Alanna, Joubert, Warren, Eastgate, Melissa and Jones, Mark (2017). Catheter-Associated Bloodstream Infections (CA-BSI) in Adults with Cancer: A Prospective Randomized Controlled Trial. In: 59th Annual Meeting of the American-Society-of-Hematology (ASH), Atlanta, GA United States, (). 9-12 December 2017. |
|
2015 Conference Publication Diagnosis of amyloidosis subtype by laser-capture microdissection (LCM) and tandem mass spectrometry (MS/MS) proteomic analysisMollee, Peter, Renaut, Patricia, Boros, Samuel, Loo, Dorothy and Hill, Michelle (2015). Diagnosis of amyloidosis subtype by laser-capture microdissection (LCM) and tandem mass spectrometry (MS/MS) proteomic analysis. 57th ASH Annual Meeting, Orlando, FL, 5-8 December 2015. American Society of Hematology. doi: 10.1182/blood.v126.23.1779.1779 |
|
2015 Conference Publication Emergence of Fc-Gamma-Riib-dominance contributes to resistance to therapeutic antibodies in patients with chronic lymphocytic leukaemiaBurgess, Melinda, Mapp, Sally, Mazzieri, Roberta, Ellis, Jonathan, Cheung, Catherine, Chambers, Lynne, Mattarollo, Stephen, Mollee, Peter, Gill, Devinder and Saunders, Nicholas (2015). Emergence of Fc-Gamma-Riib-dominance contributes to resistance to therapeutic antibodies in patients with chronic lymphocytic leukaemia. 57th Annual Meeting of the American-Society-of-Hematology, Orlando, FL USA, 5-8 December 2015. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood.v126.23.447.447 |
|
2015 Conference Publication Lenalidomide use in relapsed or refractory multiple myeloma patients at five large Queensland public hospitalsMcKavanagh, Daniel, Walpole, Euan, Hollingworth, Samantha, Sharkey, Megan and Mollee, Peter (2015). Lenalidomide use in relapsed or refractory multiple myeloma patients at five large Queensland public hospitals. COSA’s 42nd Annual Scientific Meeting. Rare Cancers: Common Goals, Hobart, TAS, Australia, 17–19 November 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. |
|
2015 Conference Publication LECT2 Amyloidosis: not just a Hispanic diseaseRamzy, J., Mollee, P., Kwok, F., Gilbertson, J., Hosking, P., Fraenkel, M., Renaut, P., Stewart, G., Booth, D. and Gibbs, S. (2015). LECT2 Amyloidosis: not just a Hispanic disease. 15th International Myeloma Workshop, Rome, Italy, 23-26 September 2015. New York, NY United States: Elsevier. doi: 10.1016/j.clml.2015.07.414 |
|
2015 Conference Publication Comparison of Freelite (TM) and N Latex serum free light chain assays in subjects with end stage renal disease on haemodialysisKennard, A., Hawley, C., Tate, J., Klingberg, S., Pretorius, C. and Mollee, P. (2015). Comparison of Freelite (TM) and N Latex serum free light chain assays in subjects with end stage renal disease on haemodialysis. 51st Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Canberra, ACT, Australia, 7-9 September 2015. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/nep.12543 |
